188 related articles for article (PubMed ID: 14964999)
21. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
22. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005.
Zazueta-Beltran J; León-Sicairos N; Muro-Amador S; Flores-Gaxiola A; Velazquez-Roman J; Flores-Villaseñor H; Canizalez-Roman A
Int J Infect Dis; 2011 Apr; 15(4):e272-6. PubMed ID: 21317004
[TBL] [Abstract][Full Text] [Related]
23. [Bactericidal therapy in patients with tuberculosis].
Krasnov VA; Ursov IG
Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
[No Abstract] [Full Text] [Related]
24. Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico.
Amaya-Tapia G; Martín-Del Campo L; Aguirre-Avalos G; Portillo-Gómez L; Covarrubias-Pinedo A; Aguilar-Benavides S
Microb Drug Resist; 2000; 6(2):143-5. PubMed ID: 10990269
[TBL] [Abstract][Full Text] [Related]
25. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
26. Will tuberculosis become resistant to all antibiotics?
Dye C; Espinal MA
Proc Biol Sci; 2001 Jan; 268(1462):45-52. PubMed ID: 12123297
[TBL] [Abstract][Full Text] [Related]
27. Trends in drug resistance of mycobacterium tuberculosis.
Hejny J
Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
[No Abstract] [Full Text] [Related]
28. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
29. Fluoroquinolone-resistant Mycobacterium tuberculosis, Pakistan, 2005-2009.
Jabeen K; Shakoor S; Chishti S; Ayaz A; Hasan R
Emerg Infect Dis; 2011 Mar; 17(3):564-6. PubMed ID: 21392465
[No Abstract] [Full Text] [Related]
30. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
[TBL] [Abstract][Full Text] [Related]
31. Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
Jain A; Dixit P; Prasad R
Tuberculosis (Edinb); 2012 Sep; 92(5):404-6. PubMed ID: 22789499
[TBL] [Abstract][Full Text] [Related]
32. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
[TBL] [Abstract][Full Text] [Related]
33. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
34. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
35. Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
Phyu S; Ti T; Jureen R; Hmun T; Myint H; Htun A; Grewal HM; Bjorvatn B
Emerg Infect Dis; 2003 Feb; 9(2):274-6. PubMed ID: 12604008
[No Abstract] [Full Text] [Related]
36. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
Velayati AA; Farnia P; Masjedi MR; Hoffner S
Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
[No Abstract] [Full Text] [Related]
37. Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.
Kayigire XA; Friedrich SO; van der Merwe L; Diacon AH
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167550
[No Abstract] [Full Text] [Related]
38. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
39. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
[TBL] [Abstract][Full Text] [Related]
40. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
